NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity. Ingram K, Samson SC, Zewdu R, Zitnay RG, et al. Oncogene 2021 Oct 23. pii: 10.1038/s41388-021-02076.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ingram K, Samson SC, Zewdu R, Zitnay RG, et al. NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity. Oncogene 2021 Oct 23. pii: 10.1038/s41388-021-02076.
PMID: 34689179